These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1524349)

  • 1. [Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases].
    Guerci AP; Burtin P; Mattei S; Lederlin P
    Ann Med Interne (Paris); 1992; 143(3):155-9. PubMed ID: 1524349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low incidence of neoplasia in heart and heart-lung transplant recipients receiving triple-drug immunosuppression.
    Olivari MT; Diekmann RA; Kubo SH; Braunlin E; Jamieson SW; Ring WS
    J Heart Transplant; 1990; 9(6):618-21. PubMed ID: 2277297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
    Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
    Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple myeloma and renal transplant.
    Cacciola E; Giustolisi R; Guglielmo P; Cacciola E
    Haematologica; 1994; 79(1):73-5. PubMed ID: 15378953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of oral non-Hodgkin's lymphoma by reduction of immunosuppressive therapy in a renal allograft recipient: a case report and review of the literature.
    Keogh PV; Fisher V; Flint SR
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Dec; 94(6):697-701. PubMed ID: 12464893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel treatment with rituximab of oropharyngeal posttransplant lymphoproliferative disorder after heart transplantation.
    Kaczmarek I; Beiras-Fernandez A; Sadoni S; Bengel D; Deutsch MA; Meiser B; Reichart B
    Exp Clin Transplant; 2005 Dec; 3(2):381-4. PubMed ID: 16417448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoproliferative disorders and hematologic malignancies following organ transplantation.
    Ferry JA; Jacobson JO; Conti D; Delmonico F; Harris NL
    Mod Pathol; 1989 Nov; 2(6):583-92. PubMed ID: 2587566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Post-transplantation lymphoproliferation in patients with intensive immunosuppression].
    Vavrinová H; Viklický O; Lácha J; Housa D; Hosková L; Teplan V
    Vnitr Lek; 2006 Jun; 52(6):645-8. PubMed ID: 16871771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression.
    Armitage JM; Kormos RL; Stuart RS; Fricker FJ; Griffith BP; Nalesnik M; Hardesty RL; Dummer JS
    J Heart Lung Transplant; 1991; 10(6):877-86; discussion 886-7. PubMed ID: 1661607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic myeloid leukemia after renal transplantation: report of a new case and review of the bibliography].
    Sanz L; Cervantes F; Esteve J; Vilardell J; Marín P; Rozman C; Montserrat E
    Sangre (Barc); 1996 Oct; 41(5):391-3. PubMed ID: 9026925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of lymphoid neoplasia after cardiothoracic transplantation: the influence of underlying disease and human leukocyte antigen type and matching.
    Higgins CD; Swerdlow AJ; Smith JD; Hunt BJ; Thomas JA; Burke MM; Crawford DH; Yacoub MH
    Transplantation; 2003 May; 75(10):1698-703. PubMed ID: 12777859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious complications in heart transplant recipients with combined low dose cyclosporine, azathioprine and prednisolone (triple drug) immunosuppression.
    Laufer G; Laczkovics A; Wollenek G; Buxbaum P; Graninger W; Holzinger C; Wolner E
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2508-11. PubMed ID: 2650315
    [No Abstract]   [Full Text] [Related]  

  • 15. Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: a case of spontaneous regression.
    Lelièvre JD; Sacre K; Adle-Biassette H; Molinier-Frenkel V; Gaulard P; Papo T
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):24-7. PubMed ID: 15692507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of immunosuppression regimen in post-transplant lymphoproliferative disorder in pediatric heart transplant patients.
    Dayton JD; Richmond ME; Weintraub RG; Shipp AT; Orjuela M; Addonizio LJ
    J Heart Lung Transplant; 2011 Apr; 30(4):420-5. PubMed ID: 21147001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosa-associated lymphoid tissue gastric lymphoma regression in a renal transplant patient after conversion of the immunosuppression to sirolimus: a case report.
    Lasmar EP; Coelho LG; Lasmar MF; Lasmar LF; Lima PV; Nogueira AF
    Transplant Proc; 2009 Apr; 41(3):959-61. PubMed ID: 19376398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    Younes BS; McDiarmid SV; Martin MG; Vargas JH; Goss JA; Busuttil RW; Ament ME
    Transplantation; 2000 Jul; 70(1):94-9. PubMed ID: 10919581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.